Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Impetus Digital Fireside Chat

- PMLiVE

Gilead and AI-focused Genesis partner to develop small molecule therapies

The companies will use Genesis’ AI platform to generate and optimise molecules for targets selected by Gilead

- PMLiVE

Eli Lilly and Genetic Leap partner to develop RNA-targeted therapies in deal worth $409m

The companies will use Genetic Leap's AI platform to generate oligonucleotide drugs against targets selected by Lilly

Clipboard inside Cuttsy+Cuttsy branded shapes

Closing the loop: Why clinical trial results matter to participants

Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.

Cuttsy + Cuttsy

- PMLiVE

UK government launches £400m investment programme to support clinical research

Up to 18 clinical trial hubs will be created to accelerate the development of new drugs

- PMLiVE

Artificial intelligence versus real insight – does pharmaceutical industry consulting face a dilemma or a progression?

By Frank Fisher and Zoë van Helmond

Amiculum

https://youtu.be/gwGFH9YhbLg

Time and Cost Savings with Virtual Medical Education – Perks of Virtual Medical Education

Step into the future of medical education with significant time and cost savings! Virtual learning allows healthcare professionals to engage in training without travel, cutting costs and conserving valuable work...

Impetus Digital

- PMLiVE

Pharma-exclusive Webinar: Virtual Publication Planning, Co-Development, & Reviews

Dive into Impetus Digital's exclusive webinar on Medical Publications to learn from experts about the latest in publication planning, co-development, and reviews, and enhance your strategies in the virtual realm.

Impetus Digital

Enhancing Continuity with Online Meetings – Perks of Virtual Medical Education

Explore the power of online meetings for superior continuity in our latest video from the "Perks of Virtual Medical Education" series. Learn how shorter, more frequent virtual touchpoints allow for...

Impetus Digital

- PMLiVE

Lancet Commission report identifies two new modifiable dementia risk factors

The new risk factors identified are untreated vision loss and high low-density lipoprotein

Equal Voice in Virtual Meetings – Perks of Virtual Medical Education

In virtual meetings, every participant has the chance to be heard. Our new video from the "Perks of Virtual Medical Education" series explores how features like chat and Q&A ensure...

Impetus Digital

- PMLiVE

Study reveals GSK’s new recombinant shingles vaccine could reduce dementia risk

Shingrix reduced dementia diagnoses by 17% compared to Merck & Co’s Zostavax after six years

- PMLiVE

Top 10 Medical Education Trends of 2024

Discover the top 10 trends revolutionizing medical education, from VR and gamification to microlearning and AI, making learning more personalized, interactive, and effective. Read the full article to explore how...

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links